Protaryx Medical Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$5.1M
- Investors
-
2
Protaryx Medical General Information
Description
Developer of transseptal access devices designed to be used for minimally invasive left heart therapies. The company's device helps to facilitate precise, and targeted septal crossing for catheter-based interventions enables zero-exchange procedures, incorporates a proprietary RF guidewire technology compatible with standard electrosurgical generators, enabling surgeons to have reliable access specifically to the left heart.
Contact Information
Website
www.protaryx.comCorporate Office
- 323 West Camden Street
- Suite 600
- Baltimore, MD 21201
- United States
Corporate Office
- 323 West Camden Street
- Suite 600
- Baltimore, MD 21201
- United States
Protaryx Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 29-Jun-2020 | $5.1M | Completed | Generating Revenue | ||
| 2. Seed Round | Completed | Startup | ||||
| 1. Grant | $187K | Completed | Startup |
Protaryx Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A1 |
Protaryx Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Protaryx Medical Patents
Protaryx Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024338448-A1 | Apparatus and method for septal penetration | Pending | 05-Sep-2023 | ||
| EP-4774029-A1 | Apparatus and method for septal penetration | Pending | 05-Sep-2023 | ||
| US-20260191583-A1 | Apparatus and method for septal penetration | Pending | 05-Sep-2023 | ||
| WO-2025054191-A1 | Apparatus and method for septal penetration | Inactive | 05-Sep-2023 | ||
| US-20250359890-A1 | Apparatus and method for septal punch | Pending | 18-May-2022 | A61B17/32053 |
Protaryx Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Protaryx Medical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ajax Health | PE/Buyout | Minority | ||
| UM Ventures | Venture Capital | Minority |
Protaryx Medical FAQs
-
When was Protaryx Medical founded?
Protaryx Medical was founded in 2019.
-
Where is Protaryx Medical headquartered?
Protaryx Medical is headquartered in Baltimore, MD.
-
What is the size of Protaryx Medical?
Protaryx Medical has 2 total employees.
-
What industry is Protaryx Medical in?
Protaryx Medical’s primary industry is Surgical Devices.
-
Is Protaryx Medical a private or public company?
Protaryx Medical is a Private company.
-
What is the current valuation of Protaryx Medical?
The current valuation of Protaryx Medical is .
-
What is Protaryx Medical’s current revenue?
The current revenue for Protaryx Medical is .
-
How much funding has Protaryx Medical raised over time?
Protaryx Medical has raised $8.11M.
-
Who are Protaryx Medical’s investors?
Ajax Health and UM Ventures have invested in Protaryx Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
